AU2002217866A1 - Geldanamycin derivatives useful for the treatment of cancer - Google Patents

Geldanamycin derivatives useful for the treatment of cancer

Info

Publication number
AU2002217866A1
AU2002217866A1 AU2002217866A AU1786602A AU2002217866A1 AU 2002217866 A1 AU2002217866 A1 AU 2002217866A1 AU 2002217866 A AU2002217866 A AU 2002217866A AU 1786602 A AU1786602 A AU 1786602A AU 2002217866 A1 AU2002217866 A1 AU 2002217866A1
Authority
AU
Australia
Prior art keywords
cancer
treatment
derivatives useful
geldanamycin derivatives
geldanamycin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002217866A
Inventor
Jennifer A. Isaacs
Leonard M. Neckers
Christopher Nicchitta
Meredith F. Rosser
Edward A. Sausville
Kenneth M. Snader
B. Roa Vishnuvajjala
Wanping Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2002217866A1 publication Critical patent/AU2002217866A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D225/00—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom
    • C07D225/04—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D225/06—Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
AU2002217866A 2000-11-06 2001-11-06 Geldanamycin derivatives useful for the treatment of cancer Abandoned AU2002217866A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US24625800P 2000-11-06 2000-11-06
US60246258 2000-11-06
US27902001P 2001-03-27 2001-03-27
US60279020 2001-03-27
US28001601P 2001-03-30 2001-03-30
US60280016 2001-03-30
PCT/US2001/044172 WO2002036574A1 (en) 2000-11-06 2001-11-06 Geldanamycin derivatives useful for the treatment of cancer

Publications (1)

Publication Number Publication Date
AU2002217866A1 true AU2002217866A1 (en) 2002-05-15

Family

ID=27399909

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002217866A Abandoned AU2002217866A1 (en) 2000-11-06 2001-11-06 Geldanamycin derivatives useful for the treatment of cancer

Country Status (2)

Country Link
AU (1) AU2002217866A1 (en)
WO (1) WO2002036574A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6872715B2 (en) 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
GB2384428A (en) * 2002-01-29 2003-07-30 Thromb X Nv Inhibitors of HIF
EP1625141A4 (en) 2003-05-12 2007-07-04 Philadelphia Children Hospital Grp94-based compositions and methods of use thereof
US20050020534A1 (en) * 2003-05-30 2005-01-27 Kosan Biosciences, Inc. Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites
US7241754B2 (en) 2003-06-13 2007-07-10 Kosan Biosciences, Inc. 2-Desmethyl ansamycin compounds
US6875863B1 (en) 2003-11-12 2005-04-05 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
CA2545457A1 (en) 2003-11-12 2005-06-23 Kosan Biosciences, Inc. 11-o-methylgeldanamycin compounds
US6887993B1 (en) 2003-11-12 2005-05-03 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
US6855705B1 (en) 2003-11-12 2005-02-15 Kosan Biosciences, Inc. 11-O-methylgeldanamycin compounds
AU2004294950A1 (en) * 2003-11-26 2005-06-16 Entelos, Inc. Treatment of rheumatoid arthritis with Hypoxia-Inducible Factor 1alpha antagonists
US7259156B2 (en) 2004-05-20 2007-08-21 Kosan Biosciences Incorporated Geldanamycin compounds and method of use
WO2008044045A1 (en) 2006-10-12 2008-04-17 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
US8466140B2 (en) 2007-09-10 2013-06-18 University Of Massachusetts Mitochondria-targeted anti-tumor agents
ES2325724B1 (en) 2008-03-11 2010-05-31 FUNDACION DE LA COMUNIDAD VALENCIANA "CENTRO DE INVESTIGACIONES PRINCIPE FELIPE" PHARMACEUTICAL COMPOSITION TO INHIBIT THE INDUCABLE TRANSCRIPTION FACTOR BY HYPOXIA. MODULATORS OF PATHOLOGICAL PROCESSES OF ANGIOGENESIS, ONCOGENESIS, INFLAMMATION, APOPTOSIS AND CELL THERAPY.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995001342A1 (en) * 1993-06-29 1995-01-12 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
AU2986800A (en) * 1999-02-08 2000-08-25 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods of inhibiting the hgf-met-upa-plasmin network

Also Published As

Publication number Publication date
WO2002036574A1 (en) 2002-05-10

Similar Documents

Publication Publication Date Title
AU2935200A (en) Compounds for the treatment of obesity
HK1047284A1 (en) 2-amino-benzoxazinone derivatives for the treatment of obesity
IL152754A0 (en) Quinazoline derivatives for the treatment of tumours
AU2002364300A1 (en) Polymer derivatives for the treatment of metals
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
EP1176964B8 (en) Uses of et743 for treating cancer
AU2000258650A1 (en) 2-piperidone compounds for the treatment of cancer
AU2002217866A1 (en) Geldanamycin derivatives useful for the treatment of cancer
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
AU2002240359A1 (en) Pharmaceutical composition for the treatment of alopecia
AU2001266838A1 (en) Inhibitors of matriptase for the treatment of cancer
AU2001290165A1 (en) Components of canola for the treatment of cancer
AU8322401A (en) Indole compounds useful for the treatment of cancer
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU6062900A (en) Substituted indole compounds and their use for the treatment of cancer
AU1916601A (en) Oncolytic combinations for the treatment of cancer
AU2001214116A1 (en) Novel paclitaxel derivatives for the treatment of cancer
AU1916501A (en) Oncolytic combinations for the treatment of cancer
AU2001285156A1 (en) Combination therapy for the treatment of migraine
HK1059782A1 (en) Indole derivatives useful for the treatment of cnsdisorders
AU1917101A (en) Oncolytic combinations for the treatment of cancer
AU1595001A (en) Oncolytic combinations for the treatment of cancer
AU2002225327A1 (en) Apparatus for aesthetic treatment
AU5552400A (en) Treatment of cancer